Skip to content
Disclosery

EXANE DERIVATIVES: DHR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DHR, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 7,581 DHR shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 7,581 shares
    Change vs previous 13F -982 shares

    1.1% of the 13F portfolio, value $1,921,701.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 8,563 shares
    Change vs previous 13F +1,175 shares

    0.71% of the 13F portfolio, value $2,511,802.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 7,388 shares
    Change vs previous 13F +57 shares

    0.59% of the 13F portfolio, value $2,430,804.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 7,331 shares
    Change vs previous 13F -808 shares

    0.56% of the 13F portfolio, value $2,231,922.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 8,139 shares
    Change vs previous 13F -317 shares

    0.53% of the 13F portfolio, value $2,252,509.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 8,456 shares
    Change vs previous 13F -2,685 shares

    0.57% of the 13F portfolio, value $1,903,349.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 11,141 shares
    Change vs previous 13F -5,281 shares

    0.75% of the 13F portfolio, value $2,474,951.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 16,422 shares
    Change vs previous 13F not available

    1.15% of the 13F portfolio, value $3,536,196.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).